Volume | 246,515 |
|
|||||
News | - | ||||||
Day High | 50.4251 | Low High |
|||||
Day Low | 47.96 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Praxis Precision Medicines Inc | PRAX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
47.96 | 47.96 | 50.4251 | 48.82 | 47.78 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,642 | 246,515 | $ 49.21 | $ 12,129,820 | - | 12.45 - 67.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:05:22 | formt | 13,303 | $ 48.84 | USD |
Praxis Precision Medicines (PRAX) Options Flow Summary
Praxis Precision Medicines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
654.5M | 13.24M | - | 2.45M | -123.28M | -9.31 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Praxis Precision Medicines News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRAX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 52.24 | 53.06 | 45.06 | 48.26 | 319,449 | -3.40 | -6.51% |
1 Month | 60.55 | 67.21 | 45.06 | 55.64 | 373,816 | -11.71 | -19.34% |
3 Months | 41.01 | 67.21 | 38.29 | 52.99 | 204,877 | 7.83 | 19.09% |
6 Months | 17.85 | 67.21 | 13.005 | 34.25 | 242,074 | 30.99 | 173.61% |
1 Year | 16.65 | 67.21 | 12.45 | 21.75 | 626,835 | 32.19 | 193.33% |
3 Years | 455.10 | 489.00 | 11.85 | 62.13 | 775,535 | -406.26 | -89.27% |
5 Years | 408.15 | 914.2575 | 11.85 | 87.70 | 694,599 | -359.31 | -88.03% |
Praxis Precision Medicines Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. |